Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.
2.

Phenotype of macular corneal dystrophy in Labrador Retrievers: A multicenter study.

Busse C, Kafarnik C, Linn-Pearl R, Volmer C, Matiasek K, Premont JE, Dulaurent T, Douet JY, Gilbert I, Jalomäki S, Trost K, Isard PF, Boyd R, Raymond I.

Vet Ophthalmol. 2019 May;22(3):294-304. doi: 10.1111/vop.12596. Epub 2019 Jan 30.

PMID:
30701649
3.

Proderm technology: a water- based lipid delivery system for dermatitis that penetrates viable epidermis and has antibacterial effects.

Charruyer A, Silvander M, Caputo-Janhager M, Raymond I, Ghadially R.

BMC Dermatol. 2019 Jan 22;19(1):2. doi: 10.1186/s12895-019-0082-8.

4.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, Torp-Pedersen C, Høfsten D, Kløvgaard L, Holmvang L, Helqvist S, Jørgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Køber LV, Engstrøm T.

Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152. Erratum in: Circulation. 2018 Dec 11;138(24):e750.

PMID:
30565996
5.

The Efficacy of a Ceramide-based Cream in Mild-to-moderate Atopic Dermatitis.

Draelos ZD, Raymond I.

J Clin Aesthet Dermatol. 2018 May;11(5):30-32. Epub 2018 May 1.

6.

Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1.

Hoffman LK, Raymond I, Kircik L.

J Drugs Dermatol. 2018 Feb 1;17(2):229-232.

PMID:
29462232
7.

Corrigendum to "Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics" [Regul. Toxicol. Pharmacol. (2017) 221-230].

de Zafra CLZ, Sasseville VG, Matsumoto S, Freichel C, Milton M, MacLachlan TK, Farman C, Raymond I, Gupta S, Newton R, Atzpodien EA, Thackaberry EA.

Regul Toxicol Pharmacol. 2017 Aug;88:364. doi: 10.1016/j.yrtph.2017.04.006. Epub 2017 Apr 18. No abstract available.

PMID:
28431771
8.

Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics.

de Zafra CLZ, Sasseville VG, Matsumoto S, Freichel C, Milton M, MacLachlan TK, Farman C, Raymond I, Gupta S, Newton R, Atzpodien EA, Thackaberry EA.

Regul Toxicol Pharmacol. 2017 Jun;86:221-230. doi: 10.1016/j.yrtph.2017.03.013. Epub 2017 Mar 16. Erratum in: Regul Toxicol Pharmacol. 2017 Aug;88:364.

PMID:
28322894
9.

Comparison between pediatric and adult adipose mesenchymal stromal cells.

Abbo O, Taurand M, Monsarrat P, Raymond I, Arnaud E, De Barros S, Auriol F, Galinier P, Casteilla L, Planat-Benard V.

Cytotherapy. 2017 Mar;19(3):395-407. doi: 10.1016/j.jcyt.2016.11.012. Epub 2016 Dec 28.

PMID:
28040462
10.

Econazole Nitrate Foam 1% Improves the Itch of Tinea Pedis.

Fleischer AB Jr, Raymond I.

J Drugs Dermatol. 2016 Sep 1;15(9):1111-4.

PMID:
27602974
11.

Optimizing hepatitis B vaccination in prison.

Perrodeau F, Pillot-Debelleix M, Vergniol J, Lemonnier F, Receveur MC, Trimoulet P, Raymond I, Le Port G, Gromb-Monnoyeur S.

Med Mal Infect. 2016 Mar;46(2):96-9. doi: 10.1016/j.medmal.2016.01.002. Epub 2016 Feb 19.

PMID:
26905392
12.

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].

Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16. French.

PMID:
26899776
13.

Generalized anxiety disorder in primary care: mental health services use and treatment adequacy.

Roberge P, Normand-Lauzière F, Raymond I, Luc M, Tanguay-Bernard MM, Duhoux A, Bocti C, Fournier L.

BMC Fam Pract. 2015 Oct 22;16:146. doi: 10.1186/s12875-015-0358-y.

14.

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].

Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009. Epub 2014 Nov 14. French.

PMID:
25455954
15.

Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study.

Holmager P, Schmidt U, Mark P, Andersen U, Dominguez H, Raymond I, Zerahn B, Nygaard B, Kistorp C, Faber J.

Clin Endocrinol (Oxf). 2015 Dec;83(6):931-7. doi: 10.1111/cen.12648. Epub 2014 Dec 17.

PMID:
25359424
16.

The clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections.

Raymond I, Vasdev N, Ferguson J, Haskin M, Davis L, Hasan TS.

Curr Urol. 2012 Sep;6(2):93-8. doi: 10.1159/000343517. Epub 2012 Sep 27.

17.

NSW Aboriginal Health Promotion Program: lessons learned and ways forward.

Raymond I, McDonnell C, Wilson G.

N S W Public Health Bull. 2012 Jun;23(3-4):57-8. doi: 10.1071/NB12067b. No abstract available.

18.

α-Defensins and outcome in patients with chronic heart failure.

Christensen HM, Frystyk J, Faber J, Schou M, Flyvbjerg A, Hildebrandt P, Raymond I, Klausen TW, Kistorp C.

Eur J Heart Fail. 2012 Apr;14(4):387-94. doi: 10.1093/eurjhf/hfs021. Epub 2012 Feb 22.

19.

Plasma calprotectin levels reflect disease severity in patients with chronic heart failure.

Jensen LJ, Kistorp C, Bjerre M, Raymond I, Flyvbjerg A.

Eur J Prev Cardiol. 2012 Oct;19(5):999-1004. doi: 10.1177/1741826711421078. Epub 2011 Sep 2.

PMID:
21890535
20.

Cardiovascular events in thyroid disease: a population based, prospective study.

Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J.

Horm Metab Res. 2011 Aug;43(9):653-9. doi: 10.1055/s-0031-1283162. Epub 2011 Aug 5.

PMID:
21823062
21.
22.

Modulation of voltage-gated ion channels in rat retinal ganglion cells mediated by somatostatin receptor subtype 4.

Farrell SR, Raymond ID, Foote M, Brecha NC, Barnes S.

J Neurophysiol. 2010 Sep;104(3):1347-54. doi: 10.1152/jn.00098.2010. Epub 2010 Jun 23.

23.

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population.

Andreassen M, Raymond I, Hildebrandt P, Kistorp C, Rathcke C, Vestergaard H, Faber J, Kristensen LO.

Inflamm Res. 2010 Jul;59(7):503-10. doi: 10.1007/s00011-009-0154-z. Epub 2010 Jan 3.

PMID:
20047081
24.

Plasma YKL-40 levels are elevated in patients with chronic heart failure.

Rathcke CN, Kistorp C, Raymond I, Hildebrandt P, Gustafsson F, Lip GY, Faber J, Vestergaard H.

Scand Cardiovasc J. 2010 Apr;44(2):92-9. doi: 10.3109/14017430903402218.

PMID:
19961288
25.

A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells.

Raymond ID, Pool AL, Vila A, Brecha NC.

Vis Neurosci. 2009 Nov;26(5-6):453-65. doi: 10.1017/S095252380999023X. Epub 2009 Nov 23.

26.

Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians.

Andreassen M, Nielsen K, Raymond I, Kristensen LØ, Faber J.

Scand J Clin Lab Invest. 2009;69(8):880-5. doi: 10.3109/00365510903165477.

PMID:
19675969
27.

Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure.

Andreassen M, Kistorp C, Raymond I, Hildebrandt P, Gustafsson F, Kristensen LØ, Faber J.

Growth Horm IGF Res. 2009 Dec;19(6):486-90. doi: 10.1016/j.ghir.2009.03.003. Epub 2009 Apr 26.

PMID:
19398211
28.

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.

Wittkop L, Breilh D, Da Silva D, Duffau P, Mercié P, Raymond I, Anies G, Fleury H, Saux MC, Dabis F, Fagard C, Thiébaut R, Masquelier B, Pellegrin I; ANRS CO3 Aquitaine Cohort.

J Antimicrob Chemother. 2009 Jun;63(6):1251-5. doi: 10.1093/jac/dkp114. Epub 2009 Mar 31.

29.

Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.

Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H.

Int J Cardiol. 2010 Aug 6;143(1):35-42. doi: 10.1016/j.ijcard.2009.01.043. Epub 2009 Feb 14.

PMID:
19223085
30.

IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.

Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J, Kristensen LØ.

Eur J Endocrinol. 2009 Jan;160(1):25-31. doi: 10.1530/EJE-08-0452. Epub 2008 Oct 17.

PMID:
18931092
31.
32.

Subclinical doses of T-2 toxin impair acquired immune response and liver cytochrome P450 in pigs.

Meissonnier GM, Laffitte J, Raymond I, Benoit E, Cossalter AM, Pinton P, Bertin G, Oswald IP, Galtier P.

Toxicology. 2008 May 2;247(1):46-54. doi: 10.1016/j.tox.2008.02.003. Epub 2008 Feb 15.

PMID:
18355953
33.

Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.

Kistorp C, Chong AY, Gustafsson F, Galatius S, Raymond I, Faber J, Lip GY, Hildebrandt P.

Eur J Heart Fail. 2008 Apr;10(4):380-7. doi: 10.1016/j.ejheart.2008.02.012. Epub 2008 Mar 17.

34.

Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice.

Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, Hildebrandt PR.

Int J Clin Pract. 2007 Sep;61(9):1481-91.

35.

Selective impairment of drug-metabolizing enzymes in pig liver during subchronic dietary exposure to aflatoxin B1.

Meissonnier GM, Laffitte J, Loiseau N, Benoit E, Raymond I, Pinton P, Cossalter AM, Bertin G, Oswald IP, Galtier P.

Food Chem Toxicol. 2007 Nov;45(11):2145-54. Epub 2007 Jun 2.

PMID:
17614185
36.

N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism.

Schultz M, Kistorp C, Langdahl B, Raymond I, Hildebrandt P, Faber J.

Thyroid. 2007 Mar;17(3):237-41.

PMID:
17381357
37.

Project: London--supporting vulnerable populations.

McColl K, Pickworth S, Raymond I.

BMJ. 2006 Jan 14;332(7533):115-7. No abstract available.

38.

Biochemical cardiac risk markers in the general population, hypertension and coronary artery disease.

Kragelund C, Kistorp C, Pedersen F, Raymond I, Hildebrandt P.

Scand J Clin Lab Invest Suppl. 2005;240:138-42.

PMID:
16112971
39.

N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events.

Pedersen F, Raymond I, Kistorp C, Sandgaard N, Jacobsen P, Hildebrandt P.

J Card Fail. 2005 Jun;11(5 Suppl):S70-5.

PMID:
15948105
40.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
41.

Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly.

Pedersen F, Raymond I, Mehlsen J, Atar D, Hildebrandt PR.

Am J Med. 2005 Jan;118(1):25-31.

PMID:
15639206
42.

Sleep disturbances, pain and analgesia in adults hospitalized for burn injuries.

Raymond I, Ancoli-Israel S, Choinière M.

Sleep Med. 2004 Nov;5(6):551-9.

PMID:
15511701
43.
44.

Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function.

Pedersen F, Raymond I, Madsen LH, Mehlsen J, Atar D, Hildebrandt P.

Eur J Heart Fail. 2004 Jun;6(4):439-47.

45.

NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.

McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ.

Eur J Heart Fail. 2004 Mar 15;6(3):269-73.

47.

[Natriuretic cardiac hormones. Clinical use in heart failure].

Nielsen SJ, Gøtze JP, Raymond IE, Grønning BA, Kirk V, Bay-Nielsen M, Hildebrandt PR, Aldershvile J.

Ugeskr Laeger. 2004 Jan 19;166(4):248-53. Review. Danish. No abstract available.

PMID:
14964102
48.

[The epidemiology of heart failure from a Danish perspective].

Nielsen OW, Raymond IE, Kirk V, Pedersen F, Bay-Nielsen M.

Ugeskr Laeger. 2004 Jan 19;166(4):243-7. Review. Danish. No abstract available.

PMID:
14964101
49.

Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen.

Raymond I, Pedersen F, Steensgaard-Hansen F, Green A, Busch-Sorensen M, Tuxen C, Appel J, Jacobsen J, Atar D, Hildebrandt P.

Heart. 2003 Dec;89(12):1422-9.

50.

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F.

Heart. 2003 Jul;89(7):745-51.

Supplemental Content

Loading ...
Support Center